"T2: mildly hyperintense"
"DWI: heterogeneously hyperintense on high b-value with moderate low signal intensity on ADC"
"DCE (Gd): avid enhancement"
"Urothelial carcinomas of the prostate were first described by Norman Ende et. al in 1963 2,4."
Expected headings
"Associations"
"Signal characteristics"
"Typical symptoms include haematuria and voiding symptoms as irritation, dysuria or other obstructive symptoms 2,3. The digital rectal examination might reveal an enlarged and/or hard prostate. Prostate-specific antigen (PSA) should not be elevated 3."
"Prostatic urothelial carcinomas can metastasise to bone, lung or liver. Bony metastases are typically osteolytic."
"Urothelial carcinomas of the prostate express urothelial cell markers as GATA3, CK7 or P63 on immunohistochemistry stains. They should be negative for prostatic cell markers as prostatic-specific antigen or NKX3-1 2,3."
"form, location and size"